Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer talked about. A caller asked if investors should take advantage ...

The U.S. is engaged in various activities from international deportation agreements to tackling AI-induced job fears. Notable developments include Google's $30 million settlement over YouTube's child ...

Rob Abbott, CEO, ISPOR, highlights how uniting regulators, payers, and academic leaders worldwide can accelerate access to innovative treatments and strengthen evidence-based healthcare.

Ten stocks took a beating on Wednesday, mimicking a mostly pessimistic broader market, as investors repositioned portfolios ...

Real world data that harnesses deidentified health records is a multi-billion-dollar industry. But what is the value of a ...

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical ...

Cell culture is a foundational technology widely used across fields such as pharmaceutical production, regenerative medicine, ...

In the third part of his Pharma Commerce video interview, Mark Lee, MarqVision’s founder and CEO, describes how AI-driven ...

The life sciences industry needs a shot of adrenaline. An aging population and a rise in chronic diseases are fueling the ...

Faster access to medicines matters to patients. For many New Zealanders, pharmaceuticals are life or death, or the difference ...

Headquartered in Massachusetts, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is a commercial-stage oncology company engaged in ...